Functional and epitope specific monoclonal antibody discovery directly from immune sera using cryoEM
Authors:
- James A. FergusonJFJames A. Ferguson
- Sai Sundar Rajan RaghavanSRSai Sundar Rajan Raghavan
- Garazi Peña AlzuaGAGarazi Peña Alzua
- Disha BhavsarDBDisha Bhavsar
- Jiachen HuangJHJiachen Huang
- Alesandra J. RodriguezARAlesandra J. Rodriguez
- Jonathan L. TorresJTJonathan L. Torres
- Maria BottermannMBMaria Bottermann
- Julianna HanJHJulianna Han
- Florian KrammerFlorian Krammer
- Facundo D. BatistaFBFacundo D. Batista
- Andrew B. WardAWAndrew B. Ward
Preprint
Abstract
Antibodies are crucial therapeutics, comprising a significant portion of approved drugs due to their safety and clinical efficacy. Traditional antibody discovery methods are labor-intensive, limiting scalability and high-throughput analysis. Here, we improved upon our streamlined approach combining structural analysis and bioinformatics to infer heavy and light chain sequences from electron potential maps of serum-derived polyclonal antibodies (pAbs) bound to antigens. Using ModelAngelo, an automated structure-building tool, we accelerated pAb sequence determination and identified sequence matches in B cell repertoires via ModelAngelo derived Hidden Markov Models (HMMs) associated with pAb structures. Benchmarking against results from a non-human primate HIV vaccine trial, our pipeline reduced analysis time from weeks to under a day with higher precision. Validation with murine immune sera from influenza vaccination revealed multiple protective antibodies. This workflow enhances antibody discovery, enabling faster, more accurate mapping of polyclonal responses with broad applications in vaccine development and therapeutic antibody discovery.Keywords
This publication has 49 references indexed in Scilit:
- Best practices for machine learning in antibody discovery and developmentDrug Discovery Today, 2024
- Eliciting a single amino acid change by vaccination generates antibody protection against group 1 and group 2 influenza A virusesImmunity, 2024
- UCSF ChimeraX : Tools for structure building and analysisProtein Science, 2023
- Principles and practical applications of structure-based vaccine designCurrent Opinion in Immunology, 2022
- Integrated analysis of multimodal single-cell dataCell, 2021
- Human Antibodies Targeting Influenza B Virus Neuraminidase Active Site Are Broadly ProtectiveImmunity, 2020
- The pharmacology and therapeutic applications of monoclonal antibodiesPharmacology Research & Perspectives, 2019
- Next-generation sequencing and protein mass spectrometry for the comprehensive analysis of human cellular and serum antibody repertoiresCurrent Opinion in Chemical Biology, 2015
- Therapeutic antibody engineering by high efficiency cell screeningFEBS Letters, 2013
- UCSF Chimera—A visualization system for exploratory research and analysisJournal of Computational Chemistry, 2004